Trial intelligence / Profile preview

Electromagnetic waves vs gabapentin for tinnitus

IRCT20130311012782N62Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of gabapentin in tinnitus (2 arms), sponsored by Isfahan University of Medical Sciences. Started Dec 2024; status: completed.

02

Drugs

gabapentin
03

Conditions

tinnitus

Beyond the preview

Go deeper on IRCT20130311012782N62.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130311012782N62.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call